Kathleen M. Murphy
Plus aucun poste en cours
Profil
Kathleen M.
Murphy was the founder of BioMarker Strategies LLC, which was founded in 2006, where she held the title of Chief Scientific Officer from 2006 to 2010.
She also worked as Vice President-Corporate Communications at Genomic Solutions, Inc. Dr. Murphy received a graduate degree from The Johns Hopkins University.
Anciens postes connus de Kathleen M. Murphy
| Sociétés | Poste | Fin |
|---|---|---|
BioMarker Strategies LLC
 BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology BioMarker Strategies LLC develops medicines for cancer. It provides cancer diagnostics system for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. The company was founded by Scott Allocco, Kathleen Murphy and Douglas P. Clark in May 2006 and is headquartered in Rockville, MD. | Fondateur | - |
Genomic Solutions, Inc.
 Genomic Solutions, Inc. Packaged SoftwareTechnology Services Genomic Solutions, Inc. designs, develops genomic and proteomic instrumentation software solutions. It provides cell based assays, gene expression analysis, array hybridization, drug discovery and assay assembly. The company was founded by Jeffrey S. Williams in 1997 and is headquartered in Ann Arbor, MI. | Public Communications Contact | - |
Formation de Kathleen M. Murphy
| The Johns Hopkins University | Graduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Genomic Solutions, Inc.
Genomic Solutions, Inc. Packaged SoftwareTechnology Services Genomic Solutions, Inc. designs, develops genomic and proteomic instrumentation software solutions. It provides cell based assays, gene expression analysis, array hybridization, drug discovery and assay assembly. The company was founded by Jeffrey S. Williams in 1997 and is headquartered in Ann Arbor, MI. | Technology Services |
BioMarker Strategies LLC
BioMarker Strategies LLC Pharmaceuticals: GenericHealth Technology BioMarker Strategies LLC develops medicines for cancer. It provides cancer diagnostics system for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. The company was founded by Scott Allocco, Kathleen Murphy and Douglas P. Clark in May 2006 and is headquartered in Rockville, MD. | Health Technology |
